Benefits and Risks of Intensive Blood Pressure Control in Patients with CKD: What Does the Current Evidence Tell Us?
By:
Allison C. Reaves William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts

Search for other papers by Allison C. Reaves in
Current site
Google Scholar
PubMed Close
and
Mark J. Sarnak William B. Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts

Search for other papers by Mark J. Sarnak in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 24: Issue 2
Published Online:
May 2025
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand
Cover Nephrology Self-Assessment Program
Copyright:
Copyright © 2025 by the American Society of Nephrology 2025
Page Count:
9
Article Category:
Research Article
Print Publication Date:
01 May 2025
Published Online:
May 2025
  • 1.

    United States Renal Data System: 2023 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Available at https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Accessed January 15, 2025

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Wu S, Li M, Lu J, Tang X, Wang G, Zheng R, et al.: China Cardiometabolic Disease and Cancer Cohort (4C) Study Group: Blood pressure levels, cardiovascular events, and renal outcomes in chronic kidney disease without antihypertensive therapy: A nationwide population-based cohort study. Hypertension 80: 640–649, 2023 10.1161/HYPERTENSIONAHA.122.19902 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    O’Seaghdha CM, Perkovic V, Lam TH, McGinn S, Barzi F, Gu DF, et al.; Asia Pacific Cohort Studies Collaboration: Blood pressure is a major risk factor for renal death: An analysis of 560 352 participants from the Asia-Pacific region. Hypertension 54: 509–515, 2009 10.1161/HYPERTENSIONAHA.108.128413 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S: Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 41: 1341–1345, 2003 10.1161/01.HYP.0000069699.92349.8C PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Park H-S, Park SH, Seong Y, Kim HJ, Choi HY, Park HC, et al.: Cumulative blood pressure load and incident CKD. Am J Kidney Dis 84: 675–685.e1, 2024 10.1053/j.ajkd.2024.05.015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al.: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol 71: e127–e248, 2018 10.1016/j.jacc.2017.11.006 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al.; ESC Scientific Document Group: 2024 ESC guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J 45: 3912–4018, 2024 10.1093/eurheartj/ehae178 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al.: 2023 ESH guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 41: 1874–2071, 2023 10.1097/HJH.0000000000003480 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al.: 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension 75: 1334–1357, 2020 10.1161/HYPERTENSIONAHA.120.15026 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Tomson CRV, Cheung AK, Mann JFE, Chang TI, Cushman WC, Furth SL, et al.: Management of blood pressure in patients with chronic kidney disease not receiving dialysis: Synopsis of the 2021 KDIGO clinical practice guideline. Ann Intern Med 174: 1270–1281, 2021 10.7326/M21-0834 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al.; Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877–884, 1994 10.1056/NEJM199403313301301 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al.; African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421–2431, 2002 10.1001/jama.288.19.2421 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, et al.; REIN-2 Study Group: Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): Multicentre, randomised controlled trial. Lancet 365: 939–946, 2005 10.1016/S0140-6736(05)71082-5 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, Cutler JA, et al.; ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362: 1575–1585, 2010 10.1056/NEJMoa1001286 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Benavente OR, Coffey CS, Conwit R, Hart RG, McClure LA, Pearce LA, et al.; SPS3 Study Group: Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial. Lancet 382: 507–515, 2013 10.1016/S0140-6736(13)60852-1 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al.; SPRINT Research Group: A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373: 2103–2116, 2015 10.1056/NEJMoa1511939 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, et al.; SPRINT Research Group: Effects of intensive BP control in CKD. J Am Soc Nephrol 28: 2812–2823, 2017 10.1681/ASN.2017020148 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Liu J, Li Y, Ge J, Yan X, Zhang H, Zheng X, et al.; ESPRIT Collaborative Group: Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: An open-label, blinded-outcome, randomised trial. Lancet 404: 245–255, 2024 10.1016/S0140-6736(24)01028-6 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Bi Y, Li M, Liu Y, Li T, Lu J, Duan P, et al.; BPROAD Research Group: Intensive blood-pressure control in patients with type 2 diabetes [published online ahead of print Nov 16, 2024]. N Engl J Med, doi:10.1056/NEJMoa2412006 2024 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, et al.: Effects of intensive systolic blood pressure lowering on cardiovascular events and mortality in patients with type 2 diabetes mellitus on standard glycemic control and in those without diabetes mellitus: Reconciling results from ACCORD BP and SPRINT. J Am Heart Assoc 7: e009326, 2018 10.1161/JAHA.118.009326 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Tsujimoto T, Kajio H: Benefits of intensive blood pressure treatment in patients with type 2 diabetes mellitus receiving standard but not intensive glycemic control. Hypertension 72: 323–330, 2018 10.1161/HYPERTENSIONAHA.118.11408 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Sarwal A, Boucher RE, Hartsell SE, Wei G, Shen J, Chertow GM, et al.: Baseline diastolic BP and BP-lowering effects on cardiovascular outcomes and all-cause mortality: A meta analysis [published online ahead of print Nov 4, 2024]. J Am Soc Nephrol doi:10.1681/ASN.0000000539 2024 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, et al.: The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the Modification of Diet in Renal Disease study. Ann Intern Med 142: 342–351, 2005 10.7326/0003-4819-142-5-200503010-00009 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, et al.; AASK Collaborative Research Group: Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 363: 918–929, 2010 10.1056/NEJMoa0910975 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Pajewski NM, Beddhu S, Bress AP, Chang TI, Chertow GM, Cheung AK, et al.: The legacy effect of intensive versus standard BP control on the incidence of needing dialysis or kidney transplantation. J Am Soc Nephrol 35: 1737–1745, 2024 10.1681/ASN.0000000000000459 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Ku E, McCulloch CE, Inker LA, Tighiouart H, Schaefer F, Wühl E, et al.: Intensive BP control in patients with CKD and risk for adverse outcomes. J Am Soc Nephrol 34: 385–393, 2023 10.1681/ASN.0000000000000072 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, et al.; SPRINT Research Group: Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis 71: 352–361, 2018 10.1053/j.ajkd.2017.08.021 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 706 706 665
Full Text Views 148 148 122
PDF Downloads 220 220 181